Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from FDA

Moderna's Cancer Vaccine Wins An FDA Boon, But Shares Drop On Mixed Earnings

Moderna stock reversed lower Thursday after the FDA granted its Merck-partnered cancer vaccine a breakthrough designation.

Investors Business Daily

FDA expands contaminated eye product warning due to potential bacterial contamination, risk of blindness

The Food and Drug Administration is adding to a list of eye-care products consumers should stop using “immediately” over concerns of possible bacterial contamination that could lead to blindness if infection occurs.

Tribune News Service

No cow needed: Oat and soy can be called milk, FDA proposes

Draft U.S. rules would allow soy, oat, almond and other drinks that bill themselves as “milk” to keep using the name

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

How abortion pills work and why they're in the spotlight

Demand for abortion pills has soared since the Supreme Court decided to overturn Roe v. Wade.

Axios

New Research Reveals Why CBD Is Such An Effective Treatment For Seizure Disorders

CBD has shown remarkable efficacy in treating seizure disorders. Now we know why this might be.

Inverse

What is naloxone and should everyone have access to it?

Two panels that advise the Food and Drug Administration are recommending that naloxone nasal spray be approved for over-the-counter sale for emergency treatment of opioid overdoses. The Joint Nonprescription Drugs Advisory Committee and the Anesthetic and Analgesic Drug Products Advisory Committee voted unanimously to approve the measure. The FDA will…

Tribune News Service

Apellis Surges To Four-Month High — Sending Rival Iveric Tumbling — On A First-Ever Approval

Apellis Pharmaceuticals snagged FDA approval for the first-ever geographic atrophy treatment, leading APLS stock to surge Tuesday.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

3 Biotech Stocks to Buy in 2023 That Could Help Set You up for Life

The biotech industry is well-positioned to witness significant growth on the backs of soaring demands and government spending. Moreover, given the sector’s defensive nature, quality biotech stocks Amgen (AMGN), Gilead Sciences (GILD), and United Therapeutics Corp. (UTHR) might be solid buys in 2023 that could help you set for life.…

StockNews.com

Editorial: Abortion pill extremists are disingenuous absolutists

When the U.S. Supreme Court overturned Roe v. Wade last year, freeing states to limit or ban abortion, we knew abortion pills would become a target.

Chicago Tribune

Liberia may have 'parallel system' for illegal log exports

A government document obtained by The Associated Press outlines more than three dozen cases in Liberia where it appears logs were illegally cut or moved out of the country using unofficial channels

The Independent UK

Starbucks vanilla drinks recalled in US over fears they may contain glass

Frappuccino not sold in stores but distributed in supermarkets by PepsiCo recalled after glass detected in 13.7oz bottles

The Guardian - US

FDA’s own reputation could be restraining its misinfo fight

The U.S. Food and Drug Administration is taking aim at a new health hazard: online misinformation

The Independent UK

3 Stocks You Won't Have Regrets About Buying in 2023

January’s robust macroeconomic reports indicate that the Fed might raise the interest rates for longer than expected. Also, the dramatic rise in consumer debt in the fourth quarter of 2022 is a red signal for the economy. Hence, fundamentally strong stocks Pfizer (PFE), CVS Health (CVS), and Universal Logistics (ULH)…

StockNews.com

What the heck is potassium sorbate? Demystifying common 'chemical sounding' food ingredients

For those aspiring to eat mainly "clean ingredients," a little chemistry knowledge is often useful for deciphering packaged food labels.

Tribune News Service

Get all your
news in one place.

100’s of premium titles.
One news app.

WEKU

More than 300,000 bottles of Starbucks bottled Frappuccinos have been recalled

The bottles of Starbucks' vanilla Frappuccinos may contain pieces of glass, the Food and Drug Administration said.

Salon

The "citizen scientist" generation rises

The author of "We the Scientists" explains how a group of parents facing the worst shook up medical research

The Street

The Food and Drug Administration has issued a voluntary recall of a popular Starbucks drink.

WEKU

Over-the-counter Narcan will save lives, experts say. But the cost will affect access

Advisers to the FDA put the opioid overdose-reversal drug a step closer to being sold without a needing a prescription. Even if approved, the medication may not reach many people who need it.

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Union chief ‘can’t imagine’ ordeal of alleged Raab bullying victims

‘You cannot underestimate how difficult it has been’ for civil servants who filed complaints against the Deputy PM, Dave Penman said.

Reuters

U.S. FDA approves Travere Therapeutics kidney disorder drug

Travere Therapeutics said on Friday the U.S. health regulator has granted accelerated approval to its drug to treat a type of chronic kidney disease, IgAN, in adults with a high risk of advancing to kidney failure.

Los Angeles Times

What happens to COVID vaccines and drugs authorized for emergency use when health emergency ends?

On May 11, the central pillar of the country's pandemic response — the declaration of a national emergency that began March 1, 2020 — will come down. But Americans will continue to have access to the vaccines, drugs and medical devices that were authorized for emergency use against COVID-19, so…

Los Angeles Times

Commentary: Will new blood donation rules finally stop stigmatizing gay men?

As a sophomore in college in 2011, I was deferred from donating blood for being a gay man. I was confronting the homophobia built into the FDA’s blood donation ban for men who have sex with men.

Tribune News Service

Your money or your life: Patient on $50,000-a-week cancer drug fears leaving behind huge medical debt

After several rounds of treatment for a rare eye cancer — weekly drug infusions that could cost nearly $50,000 each — Paul Davis learned Medicare had abruptly stopped paying the bills.

Tribune News Service

Abortion clinics prepare for more chaos with end of FDA-approved pill

Investors Business Daily

Biotech Growth Stock Boosted By FDA Approval For Multiple Sclerosis Treatment

Growth stock TG Therapeutics has surged 80% after FDA approval for its multiple sclerosis treatment.

1 … 96 97 98 99

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.